Tango Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $7.9M | — |
| FY2020 | — | $38.6M | $28.4M |
| FY2021 | — | $344.7M | $142.7M |
| FY2022 | — | $249.5M | $60.0M |
| FY2023 | — | $253.1M | $66.4M |
| FY2024 | — | $199.5M | $69.5M |
| FY2025 | — | $346.2M | $112.3M |